Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.
about
Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytesStable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.HIV-1 transcription and latency: an update.Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsTNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB.Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infectionThe host cell side of latent HIV-1 infection.Systems analysis of latent HIV reversal reveals altered stress kinase signaling and increased cell death in infected T cells.JNK, p38, ERK, and SGK1 Inhibitors in Cancer.Maraviroc is associated with latent HIV-1 reactivation through NF-κB activation in resting CD4+ T cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
P2860
Q34649701-FC75C9A7-D84C-4A1A-AB88-1CA138CD14C2Q35745365-4B9DDFA9-8831-417B-8D12-0BAAAF9DF144Q36976156-712E0547-42B3-400D-91D4-5866E3580BE2Q37273652-D3D4645E-A0EB-4F98-82F9-88816CC49DD6Q37433321-A601D307-BA71-4D0F-B23E-2451D2A8A99CQ37547710-45E0D527-51C4-41D4-9792-9632444F00EAQ38430337-2DEBBAB4-2D9B-4452-B27D-92CADEF241D9Q39026635-4D8B9D10-7383-47A8-A92F-7207EE7DC339Q39331564-64E67FF4-2F45-4F2B-B55A-A8AF9FF65610Q39794074-5F8B7E12-44C6-40AC-A0D4-C782C2C2AD38Q40253152-AB6669EB-8CD5-4C36-95A3-B56A60DDD001Q41961224-3168E657-D203-4D64-8BE8-42F0541A728FQ43113904-D1B8BA81-DA27-475C-A814-C365F63B25AAQ47096754-A3DBC325-E064-450D-BB1A-BC9926CB0151Q47265464-6945BE27-CA92-4E10-93C0-7B2CD8EBB36AQ52695029-2040180C-6E58-40CA-A226-C56D28387C36
P2860
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@en
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@nl
type
label
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@en
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@nl
prefLabel
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@en
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@nl
P2093
P2860
P50
P356
P1433
P1476
Kinase control prevents HIV-1 ...... els of induced NF-κB activity.
@en
P2093
Alberto Bosque
Jennifer Jones
Takao Shishido
Vicente Planelles
P2860
P304
P356
10.1128/JVI.06726-11
P407
P577
2012-02-15T00:00:00Z